Cargando…
Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs
PURPOSE: Chromogranin A (CgA) and neuron-specific enolase (NSE) are important markers for neuroendocrine tumors; however, the clinical value of combining these markers has not been well studied. In this study, we investigated the utility of each marker individually and in combination for patients wi...
Autores principales: | Lv, Yang, Han, Xu, Zhang, Chunyan, Fang, Yuan, Pu, Ning, Ji, Yuan, Wang, Dansong, Xuefeng, Xu, Lou, Wenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776672/ https://www.ncbi.nlm.nih.gov/pubmed/29191920 http://dx.doi.org/10.1530/EC-17-0276 |
Ejemplares similares
-
Small-cell carcinoma of the prostate with negative CD56, NSE, Syn, and CgA indicators: A case report
por: Shi, Hong-Jin, et al.
Publicado: (2022) -
Clinicopathological Characteristics and Prognosis-Related Factors of Resectable Pancreatic Neuroendocrine Tumors: A Retrospective Study of 104 Cases in a Single Chinese Center
por: Han, Xu, et al.
Publicado: (2014) -
Salivary Chromogranin A (CgA) Response to the Noradrenaline Transporter Blocker Atomoxetine in Dogs
por: Kooriyama, Takanori, et al.
Publicado: (2021) -
An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
por: Alonso-Gordoa, Teresa, et al.
Publicado: (2015) -
CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016)